How pulmonary endarterectomy affects confidence in managing chronic thromboembolic pulmonary hypertension
Official title: Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension
Run by Damascus University · NCT07272798 · Data updated 2026-11-12
This project will see if pulmonary endarterectomy helps people with chronic thromboembolic pulmonary hypertension feel more confident managing their condition.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Damascus University Academic / other |
| Locations | 1 site (Damascus, Rif-dimashq Governorate) |
| Status | Recruiting |
| Started | November 20, 2025 |
| Main results expected | November 20, 2026 |
| Study ends | November 20, 2026 |
| Registry record updated | December 17, 2025 |
| Trial ID | NCT07272798 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with CTEPH who are scheduled for elective pulmonary endarterectomy and can read, consent, and complete questionnaires are ideal candidates.
✕Probably not a fit
Patients treated only with balloon pulmonary angioplasty or medical therapy, those undergoing emergency PEA, or individuals unable to complete questionnaires due to severe cognitive or language barriers are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center prospective observational cohort will enroll adults with CTEPH scheduled for elective pulmonary endarterectomy at Damascus University Cardiac Surgery Hospital. Participants will complete validated self-efficacy questionnaires (PEPPI, SEMCD-6, SCSES) before surgery and at predefined postoperative follow-ups while functional capacity is measured using the 6-minute walk test. The analysis will link changes in patient-reported confidence with objective physical outcomes after PEA. Results aim to clarify the psychological course of recovery and inform supportive interventions.
Why it matters
Potential benefit: If successful, the findings could lead to targeted support programs that boost patients' confidence and improve recovery and daily functioning after pulmonary endarterectomy.
How similar studies have gone: This approach is novel for CTEPH—previous research has emphasized physiological and hemodynamic outcomes after PEA, and longitudinal data on cardiac self-efficacy in this population are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients undergoing pulmonary thromboendarterectomy for CTEPH * Able to read and understand the informed consent form and study questionnaires Exclusion Criteria: * Patients undergoing Balloon Pulmonary Angioplasty (BPA) or receiving only medical therapy (as the focus is on the surgical cohort). * Emergency or salvage PEA procedures (to ensure stable baseline assessment). * Inability to complete the questionnaires due to severe cognitive impairment, psychiatric illness, or language barrier.
Where it's running
-
Damascus University Cardiac Surgery Hospital
Damascus, Rif-dimashq Governorate, Syria Recruiting
Study contacts
- Study coordinator: Mohamad M Almouallem, MD
- Email: m.m.almouallem@gmail.com
- Phone: +963948376770
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up
This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.
-
Nailfold Capillaroscopy in Pulmonary Hypertension
This study tests whether nailfold capillary scans correlate with invasive lung blood pressure measurements and whether these patterns change with PH treatment.
-
Registry of people with chronic thromboembolic pulmonary hypertension in Russia
This registry collects health, history, and treatment information from people in Russia with chronic thromboembolic pulmonary hypertension to see which factors relate to their prognosis.
-
Effects of stopping riociguat on heart function in patients with CTEPH
This study is testing how stopping the medication riociguat affects heart function in patients with inoperable CTEPH who have had balloon pulmonary angioplasty.
-
Switching from Sildenafil to Riociguat for CTEPH Patients
This study is testing if switching from sildenafil to riociguat can help people with Chronic Thromboembolic Pulmonary Hypertension feel better after they’ve already had balloon pulmonary angioplasty.
-
Using AI to improve imaging for pulmonary embolism diagnosis
This study is testing if using advanced imaging and artificial intelligence can help doctors diagnose and manage pulmonary embolism better for patients who might have it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.